Market Cap 29.16B
Revenue (ttm) 4.34B
Net Income (ttm) 850.00M
EPS (ttm) N/A
PE Ratio 37.07
Forward PE 35.64
Profit Margin 19.57%
Debt to Equity Ratio 0.53
Volume 1,192,900
Avg Vol 1,911,094
Day's Range N/A - N/A
Shares Out 151.00M
Stochastic %K 16%
Beta 1.44
Analysts Sell
Price Target $198.79

Company Profile

Illumina, Inc. provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa. The company offers sequencing- and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other g...

Industry: Diagnostics & Research
Sector: Healthcare
Phone: 858 202 4500
Fax: 858 202 4766
Address:
5200 Illumina Way, San Diego, United States
tarzzanman
tarzzanman Aug. 18 at 12:20 PM
$ILMN Can we get back over 200$ this week or nah? still holding my shares from 120-165 range
0 · Reply
zero_vector
zero_vector Aug. 18 at 9:47 AM
$ILMN coiling up at the 50 day average
0 · Reply
HedgeFollow
HedgeFollow Aug. 17 at 8:31 AM
💡𝗣𝗿𝗶𝗺𝗲𝗖𝗮𝗽 13𝗙 𝗥𝗘𝗟𝗘𝗔𝗦𝗘𝗗💡 Legendary Hedge Fund manager Theofanis A. Kolokotrones submitted his latest 13F filing. 𝘔𝘰𝘴𝘵 𝘕𝘰𝘵𝘢𝘣𝘭𝘦 𝘗𝘰𝘴𝘪𝘵𝘪𝘰𝘯 𝘊𝘩𝘢𝘯𝘨𝘦𝘴: 🔹𝗡𝗲𝘄 𝗟𝗔𝗥𝗚𝗘 𝗕𝘂𝘆𝘀: $SPCX 🔹𝗔𝗱𝗱𝗲𝗱 40-50% 𝗺𝗼𝗿𝗲: $BSX and $AAL 🔹Heavily 𝗕𝗢𝗢𝗦𝗧𝗘𝗗: $ILMN 🔹𝗥𝗲𝗱𝘂𝗰𝗲𝗱 by 10-20%: Texas Inst & Micron Theo's 𝗽𝗼𝗿𝘁𝗳𝗼𝗹𝗶𝗼 𝗶𝘀 𝗨𝗣 51.50% inQ2 alone! Outstanding! Source: hedgefollow.com/funds/Primecap+Management
1 · Reply
Estimize
Estimize Aug. 10 at 2:06 PM
Wall St is expecting 1.36 EPS for $ILMN Q3 [Reporting 10/29 AMC] http://www.estimize.com/intro/ilmn?chart=historical&metric_name=eps&utm_co
0 · Reply
peakbuying
peakbuying Aug. 7 at 4:50 AM
$ILMN more coming
0 · Reply
JFDI
JFDI Aug. 6 at 11:16 PM
1 · Reply
BrendaSaxe1022
BrendaSaxe1022 Aug. 5 at 6:48 AM
$CFG $GFI $BIIB $RDDT $ILMN Citizens Financial strengthens banking operations, Gold Fields benefits from higher gold prices, Biogen advances neurological therapies, Reddit continues improving advertising monetization, and Illumina leads genomic sequencing.
0 · Reply
GabrielBarrett973
GabrielBarrett973 Aug. 5 at 5:32 AM
$ILMN $CBOE $RMD $TDY $CFG Illumina leads genomic sequencing, Cboe Global Markets benefits from exchange activity, ResMed dominates sleep therapy, Teledyne expands industrial technology, and Citizens Financial strengthens banking operations.
0 · Reply
IN0V8
IN0V8 Aug. 3 at 4:13 PM
$ILMN Canaccord Genuity raises target price to $205 from $190 Citigroup raises target price to $113 from $95 Piper Sandler raises target price to $225 from $200
0 · Reply
AnthonyCottrell683
AnthonyCottrell683 Aug. 3 at 2:47 PM
$ILMN $CBOE $RMD $TDY $CFG Illumina leads genomic sequencing, Cboe Global Markets benefits from exchange activity, ResMed dominates sleep therapy, Teledyne expands industrial technology, and Citizens Financial strengthens banking operations.
0 · Reply
Latest News on ILMN
Illumina downgraded to Hold from Buy at Freedom Broker

2026-08-05T13:56:59.000Z - 13 days ago

Illumina downgraded to Hold from Buy at Freedom Broker

ILMN


Illumina price target raised to $205 from $190 at Canaccord

2026-08-03T11:11:28.000Z - 15 days ago

Illumina price target raised to $205 from $190 at Canaccord

ILMN


Illumina price target raised to $113 from $95 at Citi

2026-08-03T10:40:55.000Z - 15 days ago

Illumina price target raised to $113 from $95 at Citi

ILMN


Illumina price target raised to $210 from $192 at TD Cowen

2026-07-31T12:59:04.000Z - 18 days ago

Illumina price target raised to $210 from $192 at TD Cowen

ILMN


Illumina price target raised to $140 from $120 at BofA

2026-07-31T12:37:33.000Z - 18 days ago

Illumina price target raised to $140 from $120 at BofA

ILMN


Illumina price target raised to $215 from $185 at Bernstein

2026-07-31T11:57:29.000Z - 18 days ago

Illumina price target raised to $215 from $185 at Bernstein

ILMN


Illumina price target raised to $225 from $155 at Stifel

2026-07-31T11:26:41.000Z - 18 days ago

Illumina price target raised to $225 from $155 at Stifel

ILMN


Illumina price target raised to $230 from $220 at JPMorgan

2026-07-31T11:20:59.000Z - 18 days ago

Illumina price target raised to $230 from $220 at JPMorgan

ILMN


Illumina price target raised to $160 from $145 at Barclays

2026-07-31T09:10:12.000Z - 19 days ago

Illumina price target raised to $160 from $145 at Barclays

ILMN


Illumina Earnings Call Transcript: Q2 2026

Jul 30, 2026, 4:30 PM EDT - 19 days ago

Illumina Earnings Call Transcript: Q2 2026


Illumina Earnings release: Q2 2026

Jul 30, 2026, 4:30 PM EDT - 19 days ago

Illumina Earnings release: Q2 2026


Illumina Slides: Q2 2026

Jul 30, 2026, 4:30 PM EDT - 19 days ago

Illumina Slides: Q2 2026


Illumina Quarterly report: Q2 2026

Jul 30, 2026, 4:30 PM EDT - 19 days ago

Illumina Quarterly report: Q2 2026


Illumina reports Q2 adjusted EPS $1.31, consensus $1.23

2026-07-30T20:11:48.000Z - 19 days ago

Illumina reports Q2 adjusted EPS $1.31, consensus $1.23

ILMN


Illumina price target raised to $210 from $175 at Leerink

2026-07-17T12:50:39.000Z - 4 weeks ago

Illumina price target raised to $210 from $175 at Leerink

ILMN


Illumina price target raised to $192 from $140 at TD Cowen

2026-07-15T12:45:54.000Z - 4 weeks ago

Illumina price target raised to $192 from $140 at TD Cowen

ILMN


Illumina price target raised to $190 from $140 at Canaccord

2026-07-14T10:56:23.000Z - 5 weeks ago

Illumina price target raised to $190 from $140 at Canaccord

ILMN


The Healthcare M&A Wave

Jun 17, 2026, 12:30 PM EDT - 2 months ago

The Healthcare M&A Wave

ABT ALNY AMGN AMRX ANTX AZN BDX


Illumina (ILMN): Bullish Structure Builds After Breakout

Jun 9, 2026, 5:10 PM EDT - 2 months ago

Illumina (ILMN): Bullish Structure Builds After Breakout

ILMN


David P. King elected to Illumina's Board of Directors

May 21, 2026, 4:15 PM EDT - 3 months ago

David P. King elected to Illumina's Board of Directors

ILMN


Illumina Transcript: AGM 2026

May 21, 2026, 1:00 PM EDT - 3 months ago

Illumina Transcript: AGM 2026


Illumina Earnings Call Transcript: Q1 2026

Apr 30, 2026, 4:30 PM EDT - 3 months ago

Illumina Earnings Call Transcript: Q1 2026


Illumina Earnings release: Q1 2026

Apr 30, 2026, 4:30 PM EDT - 3 months ago

Illumina Earnings release: Q1 2026


Illumina Slides: Q1 2026

Apr 30, 2026, 4:30 PM EDT - 3 months ago

Illumina Slides: Q1 2026


Illumina Quarterly report: Q1 2026

Apr 30, 2026, 4:30 PM EDT - 3 months ago

Illumina Quarterly report: Q1 2026


Illumina Proxy statement: Proxy filing

Apr 9, 2026, 8:00 AM EDT - 4 months ago

Illumina Proxy statement: Proxy filing


Illumina Proxy statement: Proxy filing

Apr 9, 2026, 8:00 AM EDT - 4 months ago

Illumina Proxy statement: Proxy filing


Illumina Announces Changes to Board of Directors

Apr 2, 2026, 9:07 AM EDT - 4 months ago

Illumina Announces Changes to Board of Directors

ILMN


Illumina To Webcast Upcoming Investor Conference

Feb 17, 2026, 3:10 PM EST - 6 months ago

Illumina To Webcast Upcoming Investor Conference

ILMN


Illumina Earnings Call Transcript: Q4 2025

Feb 5, 2026, 4:30 PM EST - 6 months ago

Illumina Earnings Call Transcript: Q4 2025


Illumina Annual report: Q4 2025

Feb 5, 2026, 4:30 PM EST - 6 months ago

Illumina Annual report: Q4 2025


Illumina Earnings release: Q4 2025

Feb 5, 2026, 4:30 PM EST - 6 months ago

Illumina Earnings release: Q4 2025


Illumina Slides: Q4 2025

Feb 5, 2026, 4:30 PM EST - 6 months ago

Illumina Slides: Q4 2025


Illumina completes acquisition of SomaLogic

Jan 30, 2026, 9:05 AM EST - 7 months ago

Illumina completes acquisition of SomaLogic

ILMN


Illumina Transcript: 44th Annual J.P. Morgan Healthcare Conference

Jan 13, 2026, 10:30 AM EST - 7 months ago

Illumina Transcript: 44th Annual J.P. Morgan Healthcare Conference


Illumina Slides: 44th Annual J.P. Morgan Healthcare Conference

Jan 13, 2026, 10:30 AM EST - 7 months ago

Illumina Slides: 44th Annual J.P. Morgan Healthcare Conference


Illumina unveils dataset to speed up AI-powered drug discovery

Jan 13, 2026, 9:18 AM EST - 7 months ago

Illumina unveils dataset to speed up AI-powered drug discovery

ILMN


Illumina Appoints Dr. Eric Green as Chief Medical Officer

Jan 8, 2026, 4:30 PM EST - 7 months ago

Illumina Appoints Dr. Eric Green as Chief Medical Officer

ILMN


Illumina Transcript: Wolfe Research Healthcare Conference 2025

Nov 19, 2025, 9:20 AM EST - 9 months ago

Illumina Transcript: Wolfe Research Healthcare Conference 2025


Illumina Earnings Call Transcript: Q3 2025

Oct 30, 2025, 4:30 PM EDT - 10 months ago

Illumina Earnings Call Transcript: Q3 2025


Illumina Quarterly report: Q3 2025

Oct 30, 2025, 4:30 PM EDT - 10 months ago

Illumina Quarterly report: Q3 2025


Illumina Earnings release: Q3 2025

Oct 30, 2025, 4:30 PM EDT - 10 months ago

Illumina Earnings release: Q3 2025


Illumina Slides: Q3 2025

Oct 30, 2025, 4:30 PM EDT - 10 months ago

Illumina Slides: Q3 2025


tarzzanman
tarzzanman Aug. 18 at 12:20 PM
$ILMN Can we get back over 200$ this week or nah? still holding my shares from 120-165 range
0 · Reply
zero_vector
zero_vector Aug. 18 at 9:47 AM
$ILMN coiling up at the 50 day average
0 · Reply
HedgeFollow
HedgeFollow Aug. 17 at 8:31 AM
💡𝗣𝗿𝗶𝗺𝗲𝗖𝗮𝗽 13𝗙 𝗥𝗘𝗟𝗘𝗔𝗦𝗘𝗗💡 Legendary Hedge Fund manager Theofanis A. Kolokotrones submitted his latest 13F filing. 𝘔𝘰𝘴𝘵 𝘕𝘰𝘵𝘢𝘣𝘭𝘦 𝘗𝘰𝘴𝘪𝘵𝘪𝘰𝘯 𝘊𝘩𝘢𝘯𝘨𝘦𝘴: 🔹𝗡𝗲𝘄 𝗟𝗔𝗥𝗚𝗘 𝗕𝘂𝘆𝘀: $SPCX 🔹𝗔𝗱𝗱𝗲𝗱 40-50% 𝗺𝗼𝗿𝗲: $BSX and $AAL 🔹Heavily 𝗕𝗢𝗢𝗦𝗧𝗘𝗗: $ILMN 🔹𝗥𝗲𝗱𝘂𝗰𝗲𝗱 by 10-20%: Texas Inst & Micron Theo's 𝗽𝗼𝗿𝘁𝗳𝗼𝗹𝗶𝗼 𝗶𝘀 𝗨𝗣 51.50% inQ2 alone! Outstanding! Source: hedgefollow.com/funds/Primecap+Management
1 · Reply
Estimize
Estimize Aug. 10 at 2:06 PM
Wall St is expecting 1.36 EPS for $ILMN Q3 [Reporting 10/29 AMC] http://www.estimize.com/intro/ilmn?chart=historical&metric_name=eps&utm_co
0 · Reply
peakbuying
peakbuying Aug. 7 at 4:50 AM
$ILMN more coming
0 · Reply
JFDI
JFDI Aug. 6 at 11:16 PM
1 · Reply
BrendaSaxe1022
BrendaSaxe1022 Aug. 5 at 6:48 AM
$CFG $GFI $BIIB $RDDT $ILMN Citizens Financial strengthens banking operations, Gold Fields benefits from higher gold prices, Biogen advances neurological therapies, Reddit continues improving advertising monetization, and Illumina leads genomic sequencing.
0 · Reply
GabrielBarrett973
GabrielBarrett973 Aug. 5 at 5:32 AM
$ILMN $CBOE $RMD $TDY $CFG Illumina leads genomic sequencing, Cboe Global Markets benefits from exchange activity, ResMed dominates sleep therapy, Teledyne expands industrial technology, and Citizens Financial strengthens banking operations.
0 · Reply
IN0V8
IN0V8 Aug. 3 at 4:13 PM
$ILMN Canaccord Genuity raises target price to $205 from $190 Citigroup raises target price to $113 from $95 Piper Sandler raises target price to $225 from $200
0 · Reply
AnthonyCottrell683
AnthonyCottrell683 Aug. 3 at 2:47 PM
$ILMN $CBOE $RMD $TDY $CFG Illumina leads genomic sequencing, Cboe Global Markets benefits from exchange activity, ResMed dominates sleep therapy, Teledyne expands industrial technology, and Citizens Financial strengthens banking operations.
0 · Reply
judgeyoung2
judgeyoung2 Aug. 2 at 7:20 PM
this dude has been pretty spot on. so that leaves lng sofi rddt pstg (now everpure) snow scco from his predictions. i don't think snow qualifies due to non gaap profitability and i think scco they avoid for some reason. so that leaves lng sofi rddt (we don't care about midcaps like everpure). and i'd add alny be afrm hei alab rkt. spacex is a shoe in next year... which might make it worth buying right around spring next year given it will be eligible and therefore bought up. well longing a midcap 400 right now would work if we know it's the one they're picking in the september rebalance. but which one? ilumina? twilio? fti? everpure? crs? cw? it'll be one of the top 5. and it will become clearer as august goes on. maybe $ILMN is my guess.
1 · Reply
flychicken1991
flychicken1991 Jul. 31 at 11:12 PM
$ILMN Positive (78%): shares face moderate upward pressure because the reported Q2 revenue and non-GAAP earnings beats, together with full-year revenue guidance above consensus, give analysts reason to raise forward sales and earnings estimates... Full AI impact map, source, and watch-next details: https://nimpact.tech/newsimpact/news/cab69108cf04f682?utm_source=stocktwits&utm_medium=story_url
0 · Reply
zero_vector
zero_vector Jul. 31 at 10:10 AM
$ILMN breaking out to 52 week high
0 · Reply
Estimize
Estimize Jul. 30 at 10:42 PM
$ILMN reported 1.31 EPS and 1,159 revenue for Q2. http://www.estimize.com/intro/ilmn?chart=historical&metric_name=eps&utm_content=ILMN&utm_
0 · Reply
Magnotto
Magnotto Jul. 30 at 9:31 PM
$ILMN i guess we will know tomorrow morning 🌄!.. lol
0 · Reply
wisdom_trade
wisdom_trade Jul. 30 at 9:01 PM
$ILMN growth slowing down, sell rated
0 · Reply
azstockguy
azstockguy Jul. 30 at 8:47 PM
$ILMN up 5% now down 5%. I don’t know. Not listening
0 · Reply
azstockguy
azstockguy Jul. 30 at 8:40 PM
$ILMN wtf? 😂
1 · Reply
tarzzanman
tarzzanman Jul. 30 at 8:26 PM
$ILMN Zoom out 5y chart, i dont see very much resistance coming after 220 Wall 🫣
0 · Reply
tarzzanman
tarzzanman Jul. 30 at 8:25 PM
$ILMN Love it
0 · Reply
WAJeff
WAJeff Jul. 30 at 8:24 PM
$ILMN $218, hell yeah
1 · Reply
StocktwitsEarnings
StocktwitsEarnings Jul. 30 at 8:12 PM
$ILMN Q2 '26 Earnings Results & Recap • Reported GAAP EPS of $1.37 down -8.05% YoY • Reported revenue of $1.16B up 9.44% YoY • Illumina now expects fiscal year 2026 total revenue of $4.60-$4.64 billion, ROW organic revenue growth greater than 5%, non-GAAP operating margin of 23.4%-23.6%, and non-GAAP diluted EPS of $5.30-$5.40.
0 · Reply